RR

Rajesh Ramu Deora

Active Director Director DIN 00312316
DIN 00312316 First appointment Dec 1992 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Dec 1992
Shareholding value •••• Premium profile

About Rajesh Ramu Deora

Data last updated:

Rajesh Ramu Deora is a Director at G Amphray Pharmaceuticals Private Limited (since 2005), Director at Triochem Products Limited (since 2019) and Director at Triochem Laboratories Pvt Ltd (since 2006), and holds 2 more current directorships. The companies operate in Pharma and Service. The 3 current companies with reported revenue have a combined latest revenue of ₹55.97 Cr; the largest is G Amphray Pharmaceuticals Private Limited at ₹54.89 Cr (FY 2025). Earlier, Rajesh Ramu Deora was a Director at Geniune Properties And Investments Private Limited (from 2006).

DIN 00312316
Primary Designation Director
Industry Pharma
First Appointment 07 Dec 1992
Oldest Company Age 54 yrs
Largest company G Amphray Pharmaceuticals Private Limited · ₹54.89 Cr (FY 2025)
Combined revenue ₹55.97 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jun 20051982₹54.89 Cr (FY 2025)Active
Triochem Products Limited L24249MH1972PLC015544
Director28 May 20191972₹1.05 Cr (FY 2025)Active
Triochem Laboratories Pvt Ltd U24200MH1982PTC026543
Director03 Sep 20061982₹3.3 Lakh (FY 2025)Active
Ambernath Plasto Packaging Pvt Ltd U25209MH1992PTC069778
Director07 Dec 19921992Active
Designated Partner17 Jul 20182018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Sep 20061994Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Triochem Products Limited
G Amphray Pharmaceuticals Private Limited
Triochem Laboratories Pvt Ltd
Ambernath Plasto Packaging Pvt Ltd
Premium access

Shareholding and investment profile for Rajesh Ramu Deora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Ramu Deora

Rajesh Ramu Deora currently holds 5 directorships: G Amphray Pharmaceuticals Private Limited (Director, since 21 Jun 2005, revenue ₹54.89 Cr (FY 2025)); Triochem Products Limited (Director, since 28 May 2019, revenue ₹1.05 Cr (FY 2025)); Triochem Laboratories Pvt Ltd (Director, since 03 Sep 2006, revenue ₹3.3 Lakh (FY 2025)); Ambernath Plasto Packaging Pvt Ltd (Director, since 07 Dec 1992); G Amphray Laboratories Llp (Designated Partner, since 17 Jul 2018).

Rajesh Ramu Deora was first appointed on 07 Dec 1992 as Director at Ambernath Plasto Packaging Pvt Ltd. The most recent appointment on record is 28 May 2019 at Triochem Products Limited.

The 3 current companies of Rajesh Ramu Deora that report revenue have a combined latest revenue of ₹55.97 Cr: G Amphray Pharmaceuticals Private Limited ₹54.89 Cr (FY 2025); Triochem Products Limited ₹1.05 Cr (FY 2025); Triochem Laboratories Pvt Ltd ₹3.3 Lakh (FY 2025).

Rajesh Ramu Deora held 1 earlier board appointment: Geniune Properties And Investments Private Limited (Director, from 03 Sep 2006).

The current boards of Rajesh Ramu Deora's companies include Grace Ramu Deora (G Amphray Pharmaceuticals Private Limited), Rajiv Ramu Deora (G Amphray Pharmaceuticals Private Limited), Puran Jaykisan Parmar (Triochem Products Limited), Ramu Sitaram Deora (Triochem Products Limited), Ramu Sitaram Deora (Triochem Products Limited), Shailendra Mishra (Triochem Products Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available